Life-threatening skin reaction with Enfortumab Vedotin: Six cases

Affiliations

• ¹ Dermatology Department, AP-HP, Henri Mondor Hospital, Creteil, France; Dermatology Department, AP-HP, Cochin Hospital, Paris, France, Université de Paris, Paris, France.
• ² Oncology Department, Georges Pompidou Hospital, Paris, France.
• ³ Dermatology Department, AP-HP, Cochin Hospital, Paris, France, Université de Paris, Paris, France.
• ⁴ Pathology Department, Cochin Hospital, AP-HP, AP-HP. Centre-Université de Paris, Paris, France.
• ⁵ Dermatology Department, Lyon Hospital, Lyon, France; Reference Center for Toxic Bullous Dermatoses and Serious Toxidermia TOXIBUL, Creteil, France.
• ⁶ Dermatology Department, AP-HP, Henri Mondor Hospital, Creteil, France; Reference Center for Toxic Bullous Dermatoses and Serious Toxidermia TOXIBUL, Creteil, France; EA7379 EpidermE, Créteil, France.
• ⁷ Dermatology Department, AP-HP, Cochin Hospital, Paris, France, Université de Paris, Paris, France. Electronic address: nicolas.dupin@aphp.fr.